1. Short progression‐free survival of ALK inhibitors sensitive to secondary mutations in ALK‐positive NSCLC patients. Issue 9 (23rd July 2019) Authors: Haratake, Naoki; Seto, Takashi; Takamori, Shinkichi; Toyozawa, Ryo; Nosaki, Kaname; Miura, Naoko; Ohba, Taro; Toyokawa, Gouji; Taguchi, Kenichi; Yamaguchi, Masafumi; Shimokawa, Mototsugu; Takenoyama, Mitsuhiro Journal: Thoracic cancer Issue: Volume 10:Issue 9(2019) Page Start: 1779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗